Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open Label, Pharmacokinetic Study of an Oral Hydroxyurea Solution in Children With Sickle Cell Anemia.

NCT03763656 is registered in ClinicalTrials.gov with Nova Laboratories Limited as lead sponsor.

NCT NCT03763656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03763656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open Label, Pharmacokinetic Study of an Oral Hydroxyurea Solution in Children With Sickle Cell Anemia.
Lead sponsor
Nova Laboratories Limited
Phase
Phase 1/2
Overall status
Completed
Start date
January 3, 2019
Completion date
December 29, 2021
Enrollment
33 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease, sickle cell hemoglobin c, sickle cell-beta-thalassemia, sickle-cell; hemoglobin disease, thalassemia